SUIT UP! for science! featured in the Inner West Courier

Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges.

Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.

As a medical research institute deeply committed to improving the health outcomes of all Australians, the Centenary Institute wholeheartedly endorses the principles of voice, treaty, and truth, and gives its full support to the Voice to Parliament.

Researchers, including from the Centenary Institute, have highlighted a potential link between gut microbiota (the collection of bacteria residing in the digestive system) and enduring health problems experienced by individuals who have recovered from COVID-19.